SPG vs VRTX · rev $3.55B vs P/E 30, rev $3.33B
SPG (SPG) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SPG currently screens at market cap $0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SPG and VRTX stock pages for the full models.
Not investment advice.